Key strategies for global pharma companies to reduce risk and drive growth in the China market

Next in Health

English - November 08, 2023 13:00 - 15 minutes - 10.9 MB - ★★★★★ - 25 ratings
Health & Fitness healthcare health care health policy health regulations healthcare providers healthcare payors life sciences healthcare economy health economy patient care Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: How technology is helping to transform behavioral and mental health care across the globe

Next Episode: Future-proofing behavioral health care: Innovations to ensure no one is left behind

Tune in to hear PwC specialists discuss their recently published article: How a local-first strategy in China can help global pharma and life sciences players reduce risk and drive growth. Topics include:

Sharing key strategies for pharma companies contemplating localization in China, offering valuable insights on maximizing business growth while mitigating risks in the Chinese marketThree approaches organizations can consider to competing at a local level in ChinaImpacts to different functions across the value chain such as R&D, supply chain, and IT

Speakers:
Nalneesh Gaur, Partner, Pharmaceutical and Life Sciences Cybersecurity, PwC
Ben Rhee, Principal, Pharmaceutical and Life Sciences Enterprise Strategy and Value, PwC
Igor Belokrinitsky, Strategy& Principal, PwC

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.